JP2008523056A5 - - Google Patents

Download PDF

Info

Publication number
JP2008523056A5
JP2008523056A5 JP2007545401A JP2007545401A JP2008523056A5 JP 2008523056 A5 JP2008523056 A5 JP 2008523056A5 JP 2007545401 A JP2007545401 A JP 2007545401A JP 2007545401 A JP2007545401 A JP 2007545401A JP 2008523056 A5 JP2008523056 A5 JP 2008523056A5
Authority
JP
Japan
Prior art keywords
contrast agent
reaction
imaging
vivo
optical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007545401A
Other languages
English (en)
Other versions
JP2008523056A (ja
JP5015794B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NO2005/000458 external-priority patent/WO2006065146A2/en
Publication of JP2008523056A publication Critical patent/JP2008523056A/ja
Publication of JP2008523056A5 publication Critical patent/JP2008523056A5/ja
Application granted granted Critical
Publication of JP5015794B2 publication Critical patent/JP5015794B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (6)

  1. 酵素基質を含む次の式(III)の学イメージング用造影剤。
    (R−L)r−Q−En (III)
    式中、Qは還元型の蛍光色素であって、活性化白血球によって生成するオキシダントと当該造影剤との反応によってインビボでの蛍光特性が変化する蛍光色素を表し、
    Eは酵素基質を表し、
    nは1〜3の整数を表し、
    Rは親水基を表し、
    Lはリンカーを表し、
    rは0〜4の整数である。
  2. 酵素反応に加えてオキシダントとの反応による蛍光特性の変化を含むインビボでの二段階機構で活性化される、請求項記載の光学イメージング用造影剤。
  3. Eが、ペプチダーゼ、プロテアーゼ、ホスファターゼ、スルファターゼ、グルコシダーゼ、エステラーゼ、デヒドロゲナーゼ、オキシダーゼ、レダクターゼ、キナーゼ、トランスフェラーゼ及びリガーゼからなる群から選択される酵素に対する質である、請求項又は請求項記載の光学イメージング用造影剤。
  4. インビボ光学イメージングによって組織中の活性化白血球を検出する方法であって、
    i)請求項1乃至請求項のいずれか1項記載の光学イメージング用造影剤を被検体に投与し、
    ii)造影剤の蛍光特性の変化を検出すること
    を含む方法。
  5. 造影剤が請求項に記載のものであり、Eが加水分解酵素の基質であり、造影剤がオキシダントとの反応前に酵素反応を受ける、請求項記載の方法。
  6. 請求項1乃至請求項のいずれか1項記載の造影剤を、薬学的に許容される1種以上の補助剤、賦形剤又は希釈剤と共に含んでなる組成物。
JP2007545401A 2004-12-13 2005-12-13 蛍光造影剤 Expired - Fee Related JP5015794B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20045435 2004-12-13
NO20045435 2004-12-13
PCT/NO2005/000458 WO2006065146A2 (en) 2004-12-13 2005-12-13 Fluorescent contrast agents

Publications (3)

Publication Number Publication Date
JP2008523056A JP2008523056A (ja) 2008-07-03
JP2008523056A5 true JP2008523056A5 (ja) 2009-02-05
JP5015794B2 JP5015794B2 (ja) 2012-08-29

Family

ID=35945184

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007545401A Expired - Fee Related JP5015794B2 (ja) 2004-12-13 2005-12-13 蛍光造影剤

Country Status (5)

Country Link
US (2) US20090238765A1 (ja)
EP (2) EP2025349A3 (ja)
JP (1) JP5015794B2 (ja)
CN (1) CN101115507A (ja)
WO (1) WO2006065146A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906106B2 (en) 2007-06-27 2011-03-15 General Electric Company In vivo cell trafficking
WO2009139972A2 (en) * 2008-03-31 2009-11-19 University Of Louisville Research Foundation, Inc. Site specific fluorescence marking and contrast marker for same
CN103214875B (zh) * 2013-03-04 2014-08-27 大连理工大学 一类以荧光素类似物为母体的荧光染料的合成和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263877A1 (en) * 1986-04-11 1988-04-20 The President And Fellows Of Harvard College Dihydrorhodamines and halogenated derivatives thereof
US5905031A (en) * 1995-05-18 1999-05-18 Coulter International Corp. Identification of blast cells in a leukocyte cell preparation
US5773236A (en) * 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
AU8224998A (en) * 1997-07-04 1999-01-25 Nycomed Amersham Plc Peroxidase-catalysed fluorescence
US6265179B1 (en) * 2000-02-01 2001-07-24 Molecular Probes, Inc. Detection of phosphate using coupled enzymatic reactions
WO2001066789A1 (en) 2000-03-09 2001-09-13 U.S. Army Institute Of Surgical Research Rapid screening procedure for inflammation mediators

Similar Documents

Publication Publication Date Title
Zhang et al. Fluorogenic probes for disease-relevant enzymes
Qi et al. Recent progress in the design principles, sensing mechanisms, and applications of small-molecule probes for nitroreductases
Anderson et al. Antibacterial agents: chemistry, mode of action, mechanisms of resistance and clinical applications
CA2369694A1 (en) Agent for improving ketosis
WO2007061360A3 (en) Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
MA29909B1 (fr) Derives de pyridazine
TNSN08408A1 (fr) PYRIDINE [3,4-b] PYRAZINONES
WO2005092856A8 (en) Tetrahydrocarbazoles and derivatives
ATE427926T1 (de) Cycloalkylaminderivate
JP2006061161A5 (ja)
JP2010529147A5 (ja)
MA30162B1 (fr) Nouveaux derives de pyrrole a cycles fusionnes
Nowak et al. Discovery and initial optimization of 5, 5′-disubstituted aminohydantoins as potent β-secretase (BACE1) inhibitors
JO2256B1 (en) Renin inhibitors
MA29857B1 (fr) Derives de triazolopyridine en tant qu'inhibiteurs de lipases et phospholipases
TR200103474T2 (tr) Bileşimlerin anti-bakteriyel madde olarak yeni kullanımları
CY1105479T1 (el) Παραγωγα τετραζολιου και μεθοδοι αντιμετωπισης σχετιζομενων με τον μεταβολισμο διαταραχων με αυτα
WO2009134995A3 (en) Tetrazole compounds for reducing uric acid
NO20060114L (no) Naftylenderivater som cytokrom P450-inhibitorer
MA29775B1 (fr) Derives de pyrazolone
EP1543147B1 (fr) Procede de detection de staphylococcus aureus resistants a la meticilline
RU2008142261A (ru) Фармацевтическая композиция с модифицированным высвобождением и ее применение
JP2008523056A5 (ja)
TR200103067T2 (tr) Renin inhibitörleri
NO20092248L (no) Ny forbindelse med affinitet for amyloid